Table 2 Cox regression analysis for breast cancer outcomes of General + PECS-2 group vs General group
Mortality or recurrence/total | Unadjusted | Adjusted | |||
|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | ||
OS | |||||
General | 21/252 (8.3%) | 1 (ref) | 1 (ref) | ||
General + PECS-2 | 18/251 (7.2%) | 0.81 (0.44–1.51) | 0.463 | 0.86 (0.52–1.60) | 0.602 |
RFS | |||||
General | 47/252 (18.7%) | 1 (ref) | 1 (ref) | ||
General + PECS-2 | 38/251 (15.1%) | 0.79 (0.51–1.21) | 0.193 | 0.90 (0.76–1.32) | 0.325 |
DRFS | |||||
General | 15/252 (6.0%) | 1 (ref) | 1 (ref) | ||
General + PECS-2 | 18/251 (7.6%) | 1.20 (0.60–2.23) | 0.654 | 1.29 (0.65–2.31) | 0.414 |